In this online, self-learning activity: Transthyretin-mediated amyloidosis (ATTR) is a progressive, multisystem, life-threatening disorder characterized by the extracellular deposition of misfolded, insoluble amyloid fibrils. The role of the TTR protein is to transport thyroxine and retinol-binding proteins, and it is vital for cognition, nerve regeneration, and axonal growth. TTR itself is innately amyloidogenic even without the presence of genetic mutations, which may account for wild-type ATTR (wtATTR), while a hereditary form of ATTR (hATTR) may be passed to offspring through autosomal dominant inheritance. Left untreated, the average life expectancy of ATTR is 3 to 15 years from symptom onset.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 1935 8th Avenue
Pricing
100% of listed courses are free
52 of 52 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Cardiovascular Disease
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Hematology
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Radiology
- Pediatric Transplant Hepatology
- Pulmonary Disease
- Rheumatology
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
ReleasedApr 29, 2026
-
Last day to claim creditApr 30, 2028 2 years left
-
Voxmedia LLC Seek, Find, and Treat: Best Practices for Managing Patients With Transthyretin Amyloid Polyneuropathy (ATTR-PN)
-
Cardiometabolic Health Congress (CMHC) +1 Innovative Approaches to ATTR-CM: Addressing Health Disparities in African American Populations
-
PVI, PeerView Institute for Medical Education All Together Now for ATTR-CA: Advancing Transthyretin-Targeted Therapy to Improve Outcomes Across Patient Populations
-
ScientiaCME Looking forward without losing sight: present and emerging management strategies for neovascular age-related macular degeneration
-
ScientiaCME The roadmap to optimizing geographic atrophy care: updates in risk assessment, treatment, and care pathways in late-stage age-related macular degeneration
-
ScientiaCME Present and novel approaches in the medical management of generalized pustular psoriasis: balancing out the therapeutic landscape
